Index

• Home
• Our Business
• Pharmaceuticals Division
• Global Operations
• Product Type
• Services Division
• Our Performance
• Financial Highlights
• Chairman's Statement
• Business Review
• The Business and its Markets
• Pharmaceutical Product Development
• Key Products and Specialisations
• Development Team
• Development Update
• Acquisition
• Pharmaceuticals Division
• Services Division
• Financial Review
• Our Governance
• Directors
• Senior Management
• Director's Report
• Corporate Governance
• Audit Committee Report
• Directors' Remuneration Report
• Social, Ethical and Environmental Responsibilities
• Statement of Directors' Responsibilities
• Independent Auditor's Report
• Our Financials
• Consolidated Financial Statements
• Consolidated Income Statement
• Consolidated Balance Sheet
• Consolidated Statement of Changes
• Consolidated Statement of Cash Flows
• Notes to the Financial Statements
• Notes 1 - 7
• 1. Accounting Policies
• 2. Segmental Analysis
• 3. Finance Income
• 4. Finance Expense
• 5. Adjusted Operating Profit
• 6. Profit Before Taxation
• 7. Employees
• Notes 8 - 14
• 8. Income Tax Expense
• 9. Dividends
• 10. Earnings per Share
• 11. Intangible Assets
• 12. Property, Plant and Equipment
• 13. Impairment Reviews
• 14. Deferred Taxes
• Notes 15 - 21
• 15. Inventories
• 16. Trade and Other Receivables
• 17. Cash and Cash Equivalents
• 18. Trade and Other Payables
• 19. Current Tax Liabilities
• 20. Borrowings
• 21. Financial Instruments and Related Disclosures
• Notes 22 - 29
• 22. Share Capital
• 23. Share-based Payments
• 24. Analysis of Net (Borrowings)/Cash
• 25. Operating Leases
• 26. Foreign Exchange Rates
• 27. Acquisition of Subsidiary
• 28. Critical Accounting Judgements
• 29. Related Party Transactions
• Financial History
• Company Financial Statement
• Company Balance Sheet
• Reconciliation of Movements in Shareholders' Funds
• Notes to the Financial Statements
• Notes I - VI
• I) Principal Accounting Policies of the Company
• II) Directors and Employees
• III) Auditors Remuneration
• IV) Fixed Asset Invesments
• V) Debtors
• VI) Creditors
• Notes VII - XII
• (vii) Borrowings
• (viii) Financial Instruments
• (ix) Deferred Tax
• (x) Called up Share Capital
• (xi) Reserves
• (xii) Subsidiary Undertakings
• Index
• Accessibility
• Glossary of Terms
• Company Details